Barclays Issues Positive Forecast for MetLife (NYSE:MET) Stock Price

MetLife (NYSE:METGet Free Report) had its price target increased by analysts at Barclays from $90.00 to $96.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the financial services provider’s stock. Barclays‘s price objective would indicate a potential upside of 16.90% from the company’s previous close.

Several other equities analysts have also recently weighed in on the company. TD Cowen raised their price objective on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a report on Wednesday, November 27th. Piper Sandler raised their price target on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Jefferies Financial Group upped their price objective on MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research note on Friday, September 27th. StockNews.com raised shares of MetLife from a “hold” rating to a “buy” rating in a research note on Wednesday, January 1st. Finally, Wells Fargo & Company upped their price target on shares of MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Fourteen equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $89.23.

View Our Latest Stock Report on MET

MetLife Trading Up 0.2 %

NYSE:MET opened at $82.12 on Monday. The company has a market cap of $56.86 billion, a P/E ratio of 16.56, a price-to-earnings-growth ratio of 0.76 and a beta of 1.07. MetLife has a twelve month low of $64.61 and a twelve month high of $89.05. The business has a 50 day moving average price of $82.85 and a two-hundred day moving average price of $78.81. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51.

Institutional Trading of MetLife

Several institutional investors have recently added to or reduced their stakes in the company. PFG Investments LLC lifted its holdings in shares of MetLife by 8.9% during the third quarter. PFG Investments LLC now owns 6,360 shares of the financial services provider’s stock worth $525,000 after buying an additional 520 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new position in MetLife during the third quarter worth about $2,960,000. Segall Bryant & Hamill LLC acquired a new stake in MetLife in the 3rd quarter worth about $1,074,000. Janus Henderson Group PLC boosted its holdings in MetLife by 13.9% in the 3rd quarter. Janus Henderson Group PLC now owns 90,092 shares of the financial services provider’s stock valued at $7,430,000 after purchasing an additional 11,000 shares during the period. Finally, Public Employees Retirement System of Ohio grew its position in shares of MetLife by 5.6% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 285,514 shares of the financial services provider’s stock worth $23,549,000 after purchasing an additional 15,251 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors.

About MetLife

(Get Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Recommended Stories

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.